|
市場調查報告書
整形美容手術用產品（美國產業預測：2014年及2019年）
COSMETIC SURGERY PRODUCTS (US industry forecasts for 2014 & 2019)
|
整形美容手術用產品（美國產業預測：2014年及2019年） 是由出版商The Freedonia Group在2010年12月所出版的。
這份英文市場調查報告書包含283 PAGES 價格從美金4800起跳。
美國整形美容手術用產品需求以年率6.5%持續增加，預計2014年將可達28億美金之成績。
本報告為，匯整美國整形美容手術用產品市場需求實績數據（1999年、2004年、2009年）、2014年及2019年預測、環境因素、29間主要企業簡介及市場佔有率，以下列摘要形式闡述。
簡介
第1章 實施概要
第2章 市場環境
- 整體
- 宏觀經濟展望
- 人口統計趨勢
- 消費者支出概要
- 醫師及設備趨勢
- 沙龍產業展望
- 競爭產品趨勢
- 醫療儀器市場展望
- 法規問題
- 國際活動
第3章 整形美容處理
第4章 產品
- 整體
- 注射設備
- 設備
- 植入體
- 傷口護理用拋棄式產品
- 其他
第5章 原料
第6章 產業結構
- 整體
- 市場佔有率
- 產業重組
- 競合策略
- 研究開發
- 企業合作
- 行銷
企業簡介
圖表
Abstract
US demand to grow 6.5% annually through 2014
Demand for products used in cosmetic surgery is forecast to increase 6.5
percent per year to $2.8 billion in 2014, when 16.1 million cosmetic
procedures are expected to be performed. The economic recession that began in
December 2007 impacted the cosmetic surgery industry most profoundly in
surgical procedures, which suffered large drops in 2008 and 2009. Likewise,
demand for equipment used to perform these surgeries fell more sharply than
did that for less expensive, non-invasive nonsurgical procedures. Busy
lifestyles and pervasive unemployment rates have led to rapid increases in
demand for minimally invasive procedures (such as injections and laser-based
procedures). Minimally or non-invasive procedures will continue to take market
share from invasive surgeries, although healthy growth will remain in some
areas, such as implants, where there are no notable alternatives.
Lasers, other light-based equipment to remain largest, fastest-growing
Equipment has traditionally held the largest share of the cosmetic surgery
product market, and in 2009 accounted for over one-third of demand. Purchases
of equipment were slowed by the recession and should see a strong rebound.
Lasers and other light-based systems will continue to be the largest sector of
equipment demand, and will see the fastest growth going forward as new
laser-based treatments such as noninvasive liposuction enter the market.
Injectables and implants fastest-growing products
Through 2014, injectables and implants will continue to be the two
fastestgrowing product segments. Growth in demand for injectables has boomed
since the 1990s when BOTOX (Allergan) first entered the market. Cosmetic
injections benefit from increasing societal acceptance as well as high
consumer awareness of their ability to provide a quick, noninvasive reduction
in wrinkles with no recovery time. With 2009 and 2010 market approvals of
competing botulinum toxin-based injectables, BOTOX is seeing its first direct
competition, which is expected to have significant impact on the market.
Development of newergeneration soft tissue fillers will also continue, with
this segment expected to see the fastest gains among injectables. Implants
will continue to benefit from silicone' s market re-entry in 2006, as breast
implants -- the most common aesthetic surgical procedure -- remain
fast-growing. Next-generation implant materials (so-called “gummy
bear” implants) are forecast to enter the market once they receive FDA
approval following clinical testing. These higher-value implants will drive
further value gains.
Study coverage
“Cosmetic Surgery Products” is a new Freedonia industry
study presents historical demand data (1999, 2004 and 2009) plus forecasts for
2014 and 2019 by procedure, product and raw material. The study also assesses
key market environment factors, evaluates company market share and profiles 29
US industry competitors.
This study can help you:
- Determine your market & sales potential
- Learn more about industry competitors
- Assess new products & technologies
- Identify firms to merge with or acquire
- Complement your research & planning
- Gather data for presentations
- Confirm your own internal data
- Make better business decisions
Freedonia' s methods involve:
- Establishing consistent economic and
- market forecasts
- Using input/output ratios, flow charts and
- other economic methods to quantify data
- Employing in-house analysts who meet
- stringent quality standards
- Interviewing key industry participants,
- experts and end users
- Researching a proprietary database that
- includes trade publications, government
- reports and corporate literature
Table of Contents
INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
- General
- Macroeconomic Outlook
- Demographic Trends
- Consumer Spending Outlook
- Physicians & Facility Trends
- Spa Industry Outlook
- Competitive Product Trends
- Medical Product Market Outlook
- Regulatory Issues
- International Activity
III. COSMETIC PROCEDURES
- General
- Surgical
- Reshaping
- Implants
- Breast Implants
- Other Implants
- Lifts & Tucks
- Tummy Tucks
- Facelifts
- Breast Lifts
- Forehead Lifts
- Other Lifts
- Liposuction
- Other Surgical
- Nonsurgical
- Injections
- Botulinum Toxin
- Soft Tissue Fillers
- Other Injections
- Dermal Resurfacing
- Laser Treatments
- Laser Hair Removal
- Laser Dermal Resurfacing
- Other Laser Treatments
- Other Nonsurgical
IV. PRODUCTS
- General
- Injectables
- Botulinum Toxin
- Soft Tissue Fillers
- Hyaluronic Acid
- Collagen
- Other Soft Tissue Fillers
- Other Injectables
- Equipment
- Lasers
- Hair Removal Lasers
- Dermal Resurfacing Lasers
- Other Lasers & Light-Based Systems
- Microdermabrators
- Liposuction Equipment
- Other Equipment
- Consumables
- Implants
- Breast Implants
- Other Implants
- Lip Implants
- Chin & Cheek Implants
- All Other Implants
- Wound Care Disposables
- Bandages & Dressings
- Wound Closures
- Other Wound Care Disposables
- Other Cosmetic Surgery Products
V. RAW MATERIALS
- General
- Biological Materials
- Microbial Extracts
- Collagen
- Other Biological Materials
- Polymers
- Other Raw Materials
VI. INDUSTRY STRUCTURE
- General
- Market Share
- Industry Restructuring
- Competitive Strategies
- Research & Development
- Cooperative Agreements
- Marketing
COMPANY PROFILES
- Aesthera, see Solta Medical
- Alcon Incorporated
- Allergan Incorporated
- Alma Lasers Limited
- BioForm Medical, see Merz
- Candela, see Syneron Medical
- Covidien plc
- Cutera Incorporated
- Cynosure Incorporated
- Dectro International
- DermaMed USA Incorporated
- Diamond International Corporation Pty Limited
- Dynatronics Corporation
- Ethicon, see Johnson & Johnson
- ExcellaDerm Corporation
- Genesis Biosystems Incorporated
- Genzyme Corporation
- Hoya Corporation
- Implantech Associates Incorporated
- IRIDEX Corporation
- Johnson & Johnson
- Kendall, see Covidien
- Kinetic Concepts Incorporated
- LifeCell, see Kinetic Concepts
- Lumenis Limited
- Med-Aesthetic Solutions Incorporated
- Medicis Pharmaceutical Corporation
- Mentor Worldwide, see Johnson & Johnson
- Merz GmbH & Company KGaA
- Palomar Medical Technologies Incorporated
- Q-Med AB
- Sanofi-Aventis
- Smith & Nephew plc
- Solstice Neurosciences Incorporated
- Solta Medical Incorporated
- Suneva Medical Incorporated
- Syneron Medical Limited
- Syneture, see Covidien
- 3M Company
- Other Companies Mentioned in Study
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
SECTION II -- MARKET ENVIRONMENT
- Macroeconomic Indicators
- Population & Households
- Personal Consumption Expenditures
- Physicians & Facilities
- Spa Facilities by Type
- Medical Product & Equipment Demand
SECTION III -- COSMETIC PROCEDURES
- Cosmetic Procedures Demand by Type
- Surgical Cosmetic Procedures Demand by Type
- Cosmetic Reshaping Procedures Demand by Type
- Cosmetic Implant Procedures Demand by Type
- Cosmetic Lift & Tuck Procedures Demand by Type
- Liposuction Procedures Demand by Type
- Other Surgical Cosmetic Procedures Demand by Type
- Nonsurgical Cosmetic Procedures Demand by Type
- Cosmetic Injections Demand by Type
- Cosmetic Botulinum Toxin Injections Demand
- Cosmetic Soft Tissue Filler Injections Demand by Type
- Other Cosmetic Injections Demand by Type
- Cosmetic Dermal Resurfacing Treatment Demand by Type
- Cosmetic Laser Treatment Demand by Type
- Other Nonsurgical Cosmetic Procedures Demand
SECTION IV -- PRODUCTS
- Cosmetic Surgery Product Demand by Type
- Cosmetic Injectables Demand by Type
- Cosmetic Botulinum Toxin Demand by Formulation
- Cosmetic Soft Tissue Filler Demand by Type
- Cosmetic Hyaluronic Acid Filler Demand by Formulation
- Cosmetic Collagen Filler Demand by Formulation
- Other Cosmetic Soft Tissue Filler Demand by Type
- Other Cosmetic Injectables Demand by Type
- Cosmetic Surgery Equipment Demand by Type
- Cosmetic Laser Demand by Procedure
- Microdermabrator Demand
- Liposuction Equipment Demand
- Other Cosmetic Surgery Equipment Demand by Type
- Cosmetic Surgery Consumables Demand
- Cosmetic Implant Demand by Type
- Cosmetic Breast Implant Demand by Type
- Other Cosmetic Implant Demand by Type
- Wound Care Disposables Demand in Cosmetic Surgery by Type
- Bandages & Dressings Demand in Cosmetic Surgery
- Wound Closures Demand in Cosmetic Surgery by Type
- Other Wound Care Disposables Demand in Cosmetic Surgery
- Other Cosmetic Surgery Product Demand
SECTION V -- RAW MATERIALS
- Raw Materials Demand in Cosmetic Surgery Products by Type
- Biological Materials Demand in Cosmetic Surgery Products
- Polymers Demand in Cosmetic Surgery Products
- Other Raw Materials Demand in Cosmetic Surgery Products
SECTION VI -- INDUSTRY STRUCTURE
- US Cosmetic Surgery Product Sales by Company, 2009
- Selected Acquisitions & Divestitures
- Selected Cooperative Agreements
LIST OF CHARTS
SECTION II -- MARKET ENVIRONMENT
- World Cosmetic Surgery Product Demand, 2009
SECTION III -- COSMETIC PROCEDURES
- Cosmetic Procedures Demand by Type, 1999-2019
- Surgical Cosmetic Procedures Demand by Type, 2009
- Nonsurgical Cosmetic Procedures Demand by Type, 1999-2019
- Cosmetic Soft Tissue Filler Injections Demand by Type, 1999-2019
SECTION IV -- PRODUCTS
- Cosmetic Surgery Product Demand by Type, 1999-2019
SECTION VI -- INDUSTRY STRUCTURE
- US Cosmetic Surgery Product Market Share by Company, 2009
|
